Hiv Clinical Trials
-
Publication Venue For
- Safety and pharmacokinetics of lopinavir in HIV/HCV coinfected patients with advanced liver disease.. 12:235-243. 2011
- Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients.. 10:269-275. 2009
- Cost-effectiveness of tipranavir in treatment-experienced HIV patients in the United States.. 9:225-237. 2008
- Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.. 9:126-136. 2008
- Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview.. 8:221-226. 2007
- Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-up.. 8:182-188. 2007
- Limitations of a simplification antiretroviral strategy for HIV-infected patients with decreasing adherence to a protease inhibitor regimen.. 7:210-214. 2006
- Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.. 6:312-319. 2005
- Differences in durability of treatment with initial PI-based regimens.. 4:391-399. 2003
- Overcoming resistance: virologic response to a salvage regimen with the combination of ritonavir plus indinavir.. 4:21-28. 2003
- A clinical study of the combination of 100 mg ritonavir plus 800 mg indinavir as salvage therapy: influence of increased plasma drug levels in the rate of response.. 1:13-19. 2000